HCW Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HCW Biologics and other ETFs, options, and stocks.

About HCWB

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. 

CEO
Hing C. Wong
CEOHing C. Wong
Employees
35
Employees35
Headquarters
Miramar, Florida
HeadquartersMiramar, Florida
Founded
2018
Founded2018
Employees
35
Employees35

HCWB Key Statistics

Market cap
14.04M
Market cap14.04M
Price-Earnings ratio
-0.22
Price-Earnings ratio-0.22
Dividend yield
Dividend yield
Average volume
72.35M
Average volume72.35M
High today
$2.23
High today$2.23
Low today
$2.01
Low today$2.01
Open price
$2.15
Open price$2.15
Volume
1.69M
Volume1.69M
52 Week high
$8.75
52 Week high$8.75
52 Week low
$0.25
52 Week low$0.25

Stock Snapshot

As of today, HCW Biologics(HCWB) shares are valued at $2.09. The company's market cap stands at 14.04M, with a P/E ratio of -0.22.

As of 2026-05-29, HCW Biologics(HCWB) stock has fluctuated between $2.01 and $2.23. The current price stands at $2.09, placing the stock +3.7% above today's low and -6.5% off the high.

HCW Biologics(HCWB) shares are trading with a volume of 1.69M, against a daily average of 72.35M.

During the past year, HCW Biologics(HCWB) stock moved between $0.25 at its lowest and $8.75 at its peak.

During the past year, HCW Biologics(HCWB) stock moved between $0.25 at its lowest and $8.75 at its peak.

HCWB News

Investing.com 2d
HCW Biologics CEO Wong buys $159,999 in common stock - Investing.com

...

HCW Biologics CEO Wong buys $159,999 in common stock - Investing.com
TipRanks 2d
HCW Biologics CEO buys $160K in common stock

In a regulatory filing, HCW Biologics (HCWB) disclosed at its CEO Hing bought 113,879 shares of common stock on May 22nd in a total transaction size of $160K. S...

People also own

Based on the portfolios of people who own HCWB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.